Cao Guo

1.1k total citations
28 papers, 828 citations indexed

About

Cao Guo is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Cao Guo has authored 28 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Cao Guo's work include Cancer Cells and Metastasis (7 papers), Cancer-related molecular mechanisms research (7 papers) and RNA modifications and cancer (5 papers). Cao Guo is often cited by papers focused on Cancer Cells and Metastasis (7 papers), Cancer-related molecular mechanisms research (7 papers) and RNA modifications and cancer (5 papers). Cao Guo collaborates with scholars based in China, United States and Canada. Cao Guo's co-authors include Shan Zeng, Changjing Cai, Hong Shen, Ying Han, Ganlu Deng, Ling Yin, Junli Ma, Yiyi Li, Yihong Chen and Edward Shen and has published in prestigious journals such as Scientific Reports, Journal of Cell Science and Advanced Science.

In The Last Decade

Cao Guo

27 papers receiving 818 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cao Guo China 18 527 330 211 122 116 28 828
Changjing Cai China 19 634 1.2× 371 1.1× 362 1.7× 227 1.9× 104 0.9× 52 1.2k
Hailing Lu China 19 603 1.1× 285 0.9× 286 1.4× 136 1.1× 43 0.4× 35 894
Qingzhu Gao China 14 585 1.1× 339 1.0× 86 0.4× 239 2.0× 111 1.0× 16 969
Mingxiang Ye China 17 596 1.1× 266 0.8× 226 1.1× 117 1.0× 89 0.8× 31 1.1k
Francesco Cognetti Italy 12 198 0.4× 105 0.3× 288 1.4× 106 0.9× 39 0.3× 38 589
Julie Giraud France 15 496 0.9× 198 0.6× 346 1.6× 139 1.1× 70 0.6× 25 941
Silvia Ottaviani United Kingdom 15 442 0.8× 286 0.9× 217 1.0× 104 0.9× 98 0.8× 28 843
Jian Cui China 17 413 0.8× 165 0.5× 320 1.5× 71 0.6× 48 0.4× 30 841
Yaser Mansoori Iran 18 594 1.1× 526 1.6× 70 0.3× 59 0.5× 44 0.4× 68 878

Countries citing papers authored by Cao Guo

Since Specialization
Citations

This map shows the geographic impact of Cao Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cao Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cao Guo more than expected).

Fields of papers citing papers by Cao Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cao Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cao Guo. The network helps show where Cao Guo may publish in the future.

Co-authorship network of co-authors of Cao Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Cao Guo. A scholar is included among the top collaborators of Cao Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cao Guo. Cao Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Fang, et al.. (2024). PI3Kδ Mediates Fibrosis by Patient-Derived Vitreous. Laboratory Investigation. 104(4). 102026–102026. 1 indexed citations
2.
Shi, Jing, Cao Guo, Li Yang, & Junli Ma. (2022). The long noncoding RNA TINCR promotes self-renewal of human liver cancer stem cells through autophagy activation. Cell Death and Disease. 13(11). 961–961. 20 indexed citations
3.
Cai, Changjing, Yihan Liu, Yinghui Peng, et al.. (2022). The optimal first-line treatment for patients with left-sided RAS wild-type metastatic colorectal cancer: Double-drug regimen or triple-drug regimen therapy. Frontiers in Pharmacology. 13. 1015510–1015510. 3 indexed citations
4.
Han, Ying, Yinghui Peng, Shanshan Liu, et al.. (2022). tRF3008A suppresses the progression and metastasis of colorectal cancer by destabilizing FOXK1 in an AGO-dependent manner. Journal of Experimental & Clinical Cancer Research. 41(1). 32–32. 50 indexed citations
5.
Cai, Changjing, Yinghui Peng, Edward Shen, et al.. (2022). Identification of tumour immune infiltration-associated snoRNAs (TIIsno) for predicting prognosis and immune landscape in patients with colon cancer via a TIIsno score model. EBioMedicine. 76. 103866–103866. 17 indexed citations
6.
Huang, Qiaoqiao, Ying Han, Edward Shen, et al.. (2022). MTFR2 shapes a barrier of immune microenvironment in hepatocellular carcinoma. iScience. 26(1). 105095–105095. 5 indexed citations
7.
Cai, Changjing, Xiangyang Zhang, Yihan Liu, et al.. (2021). Gut microbiota imbalance in colorectal cancer patients, the risk factor of COVID-19 mortality. Gut Pathogens. 13(1). 70–70. 16 indexed citations
8.
Cai, Changjing, Yinghui Peng, Edward Shen, et al.. (2021). A comprehensive analysis of the efficacy and safety of COVID-19 vaccines. Molecular Therapy. 29(9). 2794–2805. 89 indexed citations
9.
Cai, Changjing, Jie Long, Qiaoqiao Huang, et al.. (2021). M6A “Writer” Gene METTL14: A Favorable Prognostic Biomarker and Correlated With Immune Infiltrates in Rectal Cancer. Frontiers in Oncology. 11. 615296–615296. 16 indexed citations
10.
Han, Ying, Yinghui Peng, Yaojie Fu, et al.. (2020). MLH1 Deficiency Induces Cetuximab Resistance in Colon Cancer via Her‐2/PI3K/AKT Signaling. Advanced Science. 7(13). 2000112–2000112. 30 indexed citations
11.
Deng, Ganlu, Yihong Chen, Cao Guo, et al.. (2020). BMP4 promotes the metastasis of gastric cancer by inducing epithelial–mesenchymal transition via ID1. Journal of Cell Science. 133(11). 23 indexed citations
12.
Chen, Yihong, Ganlu Deng, Yaojie Fu, et al.. (2020). <p>FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer</p>. OncoTargets and Therapy. Volume 13. 1625–1635. 40 indexed citations
13.
Shen, Hong, Ling Yin, Ganlu Deng, et al.. (2018). Knockdown of Beclin‐1 impairs epithelial‐mesenchymal transition of colon cancer cells. Journal of Cellular Biochemistry. 119(8). 7022–7031. 48 indexed citations
14.
Deng, Ganlu, Shan Zeng, Qingqing Luo, et al.. (2018). BMP4 promotes hepatocellular carcinoma proliferation by autophagy activation through JNK1-mediated Bcl-2 phosphorylation. Journal of Experimental & Clinical Cancer Research. 37(1). 156–156. 41 indexed citations
15.
Ma, Junli, Shan Zeng, Yan Zhang, et al.. (2017). BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1/ERK/ELK1 signaling in hepatocellular carcinoma. Cancer Letters. 411. 117–129. 67 indexed citations
16.
Zeng, Shan, Yan Zhang, Junli Ma, et al.. (2017). BMP4 promotes metastasis of hepatocellular carcinoma by an induction of epithelial–mesenchymal transition via upregulating ID2. Cancer Letters. 390. 67–76. 35 indexed citations
17.
Deng, Ganlu, Shan Zeng, Junli Ma, et al.. (2017). The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma. Scientific Reports. 7(1). 41616–41616. 64 indexed citations
18.
Guo, Cao, Junli Ma, Ganlu Deng, et al.. (2017). ZEB1 Promotes Oxaliplatin Resistance through the Induction of Epithelial - Mesenchymal Transition in Colon Cancer Cells. Journal of Cancer. 8(17). 3555–3566. 41 indexed citations
19.
Zhang, Yan, Shan Zeng, Junli Ma, et al.. (2016). Nestin overexpression in hepatocellular carcinoma associates with epithelial-mesenchymal transition and chemoresistance. Journal of Experimental & Clinical Cancer Research. 35(1). 111–111. 38 indexed citations
20.
Guo, Cao. (1998). Retrovirus mediated antisense RNA to bcl 2 alter the biological behavior of stomach carcinoma MGC 803 cell lines. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Changjing Cai Breakdown of academic impact, for papers by Hailing Lu Breakdown of academic impact, for papers by Qingzhu Gao Breakdown of academic impact, for papers by Mingxiang Ye Breakdown of academic impact, for papers by Francesco Cognetti Breakdown of academic impact, for papers by Julie Giraud Breakdown of academic impact, for papers by Silvia Ottaviani Breakdown of academic impact, for papers by Jian Cui Breakdown of academic impact, for papers by Yaser Mansoori
Rankless by CCL
2026